<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[drug Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/drug.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to drug]]></description>
	<s:counts start="0" returned="20" found="74" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Information Overload is an Addiction]]></title>
		<link><![CDATA[http://blogs.bnet.com/harvard/?p=4867]]></link>
		<description><![CDATA[If we wanted to tame information overload, we would have done so. But it's got us like a drug that provides a constant high. Can we break away from the 24/7 tether? by Sean Silverthorne]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 16 Dec 2009 07:55:55 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/sean+silverthorne.html"><![CDATA[Sean Silverthorne]]></category>
	</item>
	<item>
		<title><![CDATA[FDA Dislikes Canadian Drugs; Is OK With Chinese Drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005764/fda-dislikes-canadian-drugs-is-ok-with-chinese-drugs/]]></link>
		<description><![CDATA[FDA Commissioner Margaret Hamburg said that allowing reimportation of drugs from Canada raised significant safety questions, in a letter to to Republican Sen. Sam Brownback of Kansas, according to the Wall Street Journal. The story notes that the drug industry lobby group PhRMA also opposes reimportation and has been fighting...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 10 Dec 2009 08:37:39 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Solvay's Alleged Off-Label Switcheroo: 2 Legit Indications Reversed]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005749/solvays-alleged-off-label-switcheroo-2-legit-indications-reversed/]]></link>
		<description><![CDATA[Here's a new twist on the off-label sales racket: Rather than inventing new, unapproved uses for a drug, why not take a pair of the drug's existing approvals for separate conditions and switch them around? by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 09 Dec 2009 12:49:43 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/solvay.html"><![CDATA[Solvay]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Viagra Now Available Intravenously]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005465/viagra-now-available-intravenously/]]></link>
		<description><![CDATA[Well, not quite. The FDA appoved Pfizer PFE's pulmonary arterial hypertension drug Revatio as an injection in cases where the patient is unable to swallow the tablets. Of course, Revatio sildenafil is the same drug as Viagra. It just has a different name and a different set of indications and...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 23 Nov 2009 06:46:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/tablets.html"><![CDATA[Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks.html"><![CDATA[Notebooks]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks+%2526+tablets.html"><![CDATA[Notebooks & Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-363239.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions.  Your first question comes from the line of Ted Tenthoff with Piper Jaffray.  Ted Tenthoff &#8211; Piper Jaffray Tom, you touched on this a little bit on the call, but what actually still has to be done in preparation of the NDA...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 09 Nov 2009 19:33:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/alexza+pharmaceuticals+inc..html"><![CDATA[Alexza Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/agitation.html"><![CDATA[Agitation]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALXA</category>
		<category domain="tickers">ALXA</category>
	</item>
	<item>
		<title><![CDATA[In Risperdal Kickback Case, One Nursing Home Patient Received 67 Different Drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005149/in-risperdal-kickback-case-one-nursing-home-patient-received-67-different-drugs/]]></link>
		<description><![CDATA[The scariest wrinkle in the Omnicare kickback case is just how vulnerable old people in nursing homes are to schemes in which drug companies allegedly induce pharmacies to prescribe drugs they otherwise wouldn't. One patient cited by the government's complaint received 67 -- sixty-seven! -- different drugs under Omnicare's "care."...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 05 Nov 2009 12:28:58 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Why Estimates of Future Revenues for Obesity Drugs Are Likely Off the Mark]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004893/why-estimates-of-future-revenues-for-obesity-drugs-are-likely-off-the-mark/]]></link>
		<description><![CDATA[The total annual revenue for all obesity drugs is just $173 million in the United States. So why do people believe that Vivus, Arena and Orexigen will generate $1 billion to $10 billion with their as-yet unapproved drugs? by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 19 Oct 2009 12:32:22 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[A Look at What Those Elan Releases Under SEC Probe Actually Say]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004526/a-look-at-what-those-elan-releases-under-sec-probe-actually-say/]]></link>
		<description><![CDATA[Johnson & Johnson must be loving their new deal with Elan. Remember, this was the deal in which they paid $1.4 billion for a stake in the company, including $500 million for its Alzheimerâ€™s drugs, such as bapineuzumab. J&J now finds that its new partner is under investigation by the...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 30 Sep 2009 10:23:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">JNJ</category>
	</item>
	<item>
		<title><![CDATA[Shire Contemplates Off-Label Use of Intuniv, Vyvanse]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004095/shire-contemplates-off-label-use-of-intuniv-vyvanse/]]></link>
		<description><![CDATA[The FDA's approval of Intuniv brings to four the number of drugs for ADHD currently marketed by Shire. Management is already contemplating whether the drugs will be used off-label. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 04 Sep 2009 08:42:26 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/shire.html"><![CDATA[Shire]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Hands Off Healthcare! Sales Are Up!]]></title>
		<link><![CDATA[http://blogs.bnet.com/salesmachine/?p=5122]]></link>
		<description><![CDATA[The U.S. Healthcare system is the most successful industry in the entire world.Â  Other industries worldwide view it as THE ROLE MODEL for how to build a strong and vibrant business. Under the circumstances, it is insane to even contemplate the idea of "reform."    Here's a perfect...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 03 Sep 2009 05:30:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/washington.html"><![CDATA[Washington]]></category>
		<category domain="http://resources.bnet.com/topic/industry.html"><![CDATA[Industry]]></category>
		<category domain="http://resources.bnet.com/topic/health+care.html"><![CDATA[Health Care]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+healthcare+system.html"><![CDATA[U.S. Healthcare System]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/strategy.html"><![CDATA[Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/geoffrey+james.html"><![CDATA[Geoffrey James]]></category>
	</item>
	<item>
		<title><![CDATA[Galderma Distributed Bogus PI for Skin Drug, FDA Claims]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003854/galderma-distributed-bogus-pi-for-skin-drug-fda-claims/]]></link>
		<description><![CDATA[Galderma Labs distributed a bogus product label for its Tri-Luma Cream that falsely claimed the drug was for long-term use and failed to note that it can cause birth defects if used by pregnant women, the FDA said. Tri-Luma, for hyperpigmenation, is approved only for short-term use and can cause...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 24 Aug 2009 10:07:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Cancer drug audit set for late start]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F0%2F43518fb8-8874-11de-82e4-00144feabdc0.html&siteid=23&tag=financialtimes]]></link>
		<description><![CDATA[ Eight months after promising to audit the demand for cancer and other drugs that the NHS declines to fund, pilot projects to achieve that have yet to be launched, the Department of Health said yesterday.The pilot schemes should finally begin "later this year", a spokesman said as the Rarer...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<pubDate>Thu, 13 Aug 2009 19:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/audit.html"><![CDATA[Audit]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/cancer.html"><![CDATA[Cancer]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/general+news.html"><![CDATA[General News]]></category>
		<category domain="http://resources.bnet.com/topic/government+news.html"><![CDATA[Government News]]></category>
		<category domain="http://resources.bnet.com/topic/government+spending.html"><![CDATA[Government Spending]]></category>
		<category domain="http://resources.bnet.com/topic/health+%2526+healthcare.html"><![CDATA[Health & Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/financial+times.html"><![CDATA[Financial Times]]></category>
	</item>
	<item>
		<title><![CDATA[XOMA Ltd. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-329641.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Certainly. Operator instructions. We will go first to Liana Moussatos with Wedbush. Liana Moussatos &#8211; Wedbush Thank you. Can you talk a little bit about the design of the phase II trial and when do you think you will release data? And then second, can you describe...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Fri, 07 Aug 2009 03:05:42 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/xoma.html"><![CDATA[Xoma]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">XOMA</category>
		<category domain="tickers">XOMA</category>
	</item>
	<item>
		<title><![CDATA[FDA Says Cheerios Advertised as an Illegal Drug; Threatens to Seize Every Box in the U.S.]]></title>
		<link><![CDATA[http://industry.bnet.com/advertising/10002097/fda-says-cheerios-advertised-as-an-illegal-drug-threatens-to-seize-every-box-in-the-us/]]></link>
		<description><![CDATA[The FDA has accused General Mills of illegally marketing Cheerios as a drug because of advertising claims that the cereal can lower cholesterol. (Cheerios is handled by Saatchi & Saatchi.) by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 13 May 2009 08:20:35 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Amylin May Abandon the "Byetta" Name for Exenatide Once Weekly]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002062/amylin-may-abandon-the-byetta-name-for-exenatide-once-weekly/]]></link>
		<description><![CDATA[The launch of exenatide once weekly is crucial to Amylin but the company has not yet made a decision on whether it will extend the "Byetta" brand name to the new drug. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 11 May 2009 08:12:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/brand+name.html"><![CDATA[Brand Name]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Landmark Ruling On Drug Cases]]></title>
		<link><![CDATA[http://moneywatch.bnet.com/economic-news/video/landmark-ruling-on-drug-cases/275964/]]></link>
		<description><![CDATA[In the wake of a recent lawsuit involving the drug company Wyeth, the Supreme Court has ruled that the FDA is not exclusively responsible for the safety of prescription drugs. Wyatt Andrews reports.]]></description>
		<s:doctype><![CDATA[Videos]]></s:doctype>
		<pubDate>Wed, 15 Apr 2009 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/moneywatch.html"><![CDATA[MoneyWatch]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/evening.html"><![CDATA[Evening]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[Prescription]]></category>
		<category domain="http://resources.bnet.com/topic/medicine.html"><![CDATA[Medicine]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/health.html"><![CDATA[Health]]></category>
		<category domain="http://resources.bnet.com/topic/law.html"><![CDATA[Law]]></category>
		<category domain="http://resources.bnet.com/topic/legal.html"><![CDATA[Legal]]></category>
		<category domain="http://resources.bnet.com/topic/justice.html"><![CDATA[Justice]]></category>
		<category domain="http://resources.bnet.com/topic/federal.html"><![CDATA[Federal]]></category>
	</item>
	<item>
		<title><![CDATA[Vivus Beating Arena, Orexigen In Obesity Graveyard Race]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001541/vivus-beating-arena-orexigen-in-obesity-graveyard-race/]]></link>
		<description><![CDATA[The race to produce a blockbuster anti-obesity pill -- a contest that no company has yet won -- got interesting this week with the news, via AP, that Arena Pharmaceuticals' data showed that its contender, lorcaserin, showed only 3.6 percent more effectiveness than a placebo. The FDA wants to see...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 31 Mar 2009 11:41:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Is Cephalon's Provigil Addictive? Ask the Cocaine-Using Monkeys It Was Tested On.]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001397/is-cephalons-provigil-addictive-ask-the-cocaine-using-monkeys-it-was-tested-on/]]></link>
		<description><![CDATA[Cephalon is dealing with a PR storm over the question of whether Provigil, its sleep disorder drug, is addictive or not. A study by the National Institute on Drug Abuse suggests that it is:  Nora D. Volkow, MD, director of the National Institute on Drug Abuse NIDA, report[s] evidence...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Mar 2009 20:45:02 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cephalon+inc..html"><![CDATA[Cephalon Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/monkey.html"><![CDATA[Monkey]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/provigil.html"><![CDATA[Provigil]]></category>
		<category domain="http://resources.bnet.com/topic/modafinil.html"><![CDATA[Modafinil]]></category>
		<category domain="http://resources.bnet.com/topic/public+relations.html"><![CDATA[Public Relations]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+communications.html"><![CDATA[Corporate Communications]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CEPH</category>
		<category domain="tickers">CEPH</category>
	</item>
	<item>
		<title><![CDATA[Arena Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-278236.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions.   Our first question will come from Alan Carr with Needham. Alan Carr &#8211; Needham  Could you clarify a bit your financial guidance for &#8217;08?  You said that your expenses for this year, you ended with 110, but I was wondering...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Thu, 12 Mar 2009 20:19:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/needham+%2526+co..html"><![CDATA[Needham & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/arena+pharmaceuticals+inc..html"><![CDATA[Arena Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARNA</category>
		<category domain="tickers">ARNA</category>
	</item>
	<item>
		<title><![CDATA[Tianyin Pharmaceutical Co., Inc. F2Q09 (Qtr End 12/31/08)Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-274173.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator (Operator's instruction) Your first question comes from the line of Dean Hebert. Dean Hebert &#8211; Private Investor It is Dean Hebert. Actually I am just an investor and I have a question relating to your growth plan for next year. You mentioned you want to grow organically...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<pubDate>Mon, 02 Mar 2009 06:03:17 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
	</item>
</channel>
</rss>
